TABLE 2.
Anti-B. melitensis LPS IgM ELISA titers of mouse seraa
| Group | Vaccine | Anti-B. melitensis LPS IgM ELISA titer (mean ± SD)
|
|||
|---|---|---|---|---|---|
| 4 wk after first dose | 4 wk after second dose | 1 wk after challenge | 8 wk after challenge | ||
| 1 | B. melitensis LPS, s.c. | 368 ± 255 | 386 ± 82 | 299 ± 128 | 200 ± 103 |
| 2 | B. melitensis LPS, i.n. | 112 ± 37 | 132 ± 96 | 116 ± 86 | 91 ± 63 |
| 3 | B. melitensis LPS-GBOMP, s.c. | 794 ± 220 | 449 ± 104 | 280 ± 91 | 162 ± 63 |
| 4 | B. melitensis LPS-GBOMP, i.n. | 96 ± 51 | 166 ± 82 | 165 ± 93 | 107 ± 78 |
| 5 | Saline control | <4 | <2 | <3 | 166 ± 168 |
Mice were immunized either s.c. or i.n. Two doses of vaccine were given 4 weeks apart. Mice were challenged intranasally 4 weeks after the second dose. Sera were collected from five mice of each group at 4 weeks after the dose, 4 weeks after the second dose, and 1 week after challenge and from 18 to 20 mice of each group at 8 weeks after challenge. The data are expressed in OD units.